Titre : Troubles liés aux opiacés

Troubles liés aux opiacés : Questions médicales fréquentes

Termes MeSH sélectionnés :

Program Evaluation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Troubles liés aux opiacés : Questions médicales les plus fréquentes", "headline": "Troubles liés aux opiacés : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Troubles liés aux opiacés : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-06", "dateModified": "2025-05-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Troubles liés aux opiacés" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Troubles liés à l'usage de substances psychotropes", "url": "https://questionsmedicales.fr/mesh/D000079524", "about": { "@type": "MedicalCondition", "name": "Troubles liés à l'usage de substances psychotropes", "code": { "@type": "MedicalCode", "code": "D000079524", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.900.647" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dépendance à l'héroïne", "alternateName": "Heroin Dependence", "url": "https://questionsmedicales.fr/mesh/D006556", "about": { "@type": "MedicalCondition", "name": "Dépendance à l'héroïne", "code": { "@type": "MedicalCode", "code": "D006556", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.900.647.500.300" } } }, { "@type": "MedicalWebPage", "name": "Dépendance à la morphine", "alternateName": "Morphine Dependence", "url": "https://questionsmedicales.fr/mesh/D009021", "about": { "@type": "MedicalCondition", "name": "Dépendance à la morphine", "code": { "@type": "MedicalCode", "code": "D009021", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.900.647.500.600" } } }, { "@type": "MedicalWebPage", "name": "Surdose d'opiacés", "alternateName": "Opiate Overdose", "url": "https://questionsmedicales.fr/mesh/D000083682", "about": { "@type": "MedicalCondition", "name": "Surdose d'opiacés", "code": { "@type": "MedicalCode", "code": "D000083682", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.900.647.500.700" } } }, { "@type": "MedicalWebPage", "name": "Dépendance à l'opium", "alternateName": "Opium Dependence", "url": "https://questionsmedicales.fr/mesh/D000074607", "about": { "@type": "MedicalCondition", "name": "Dépendance à l'opium", "code": { "@type": "MedicalCode", "code": "D000074607", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.900.647.500.800" } } } ], "about": { "@type": "MedicalCondition", "name": "Troubles liés aux opiacés", "alternateName": "Opioid-Related Disorders", "code": { "@type": "MedicalCode", "code": "D009293", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sharon L Walsh", "url": "https://questionsmedicales.fr/author/Sharon%20L%20Walsh", "affiliation": { "@type": "Organization", "name": "Department of Behavioral Science, College of Medicine, University of Kentucky, Lexington, KT, USA." } }, { "@type": "Person", "name": "Michelle R Lofwall", "url": "https://questionsmedicales.fr/author/Michelle%20R%20Lofwall", "affiliation": { "@type": "Organization", "name": "Center on Drug and Alcohol Research, University of Kentucky, Lexington." } }, { "@type": "Person", "name": "Kevin Y Xu", "url": "https://questionsmedicales.fr/author/Kevin%20Y%20Xu", "affiliation": { "@type": "Organization", "name": "Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine in St Louis, St Louis, Missouri." } }, { "@type": "Person", "name": "Richard A Grucza", "url": "https://questionsmedicales.fr/author/Richard%20A%20Grucza", "affiliation": { "@type": "Organization", "name": "Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine in St Louis, St Louis, Missouri." } }, { "@type": "Person", "name": "Elizabeth E Krans", "url": "https://questionsmedicales.fr/author/Elizabeth%20E%20Krans", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Womens Research Institute, 300 Halket Street, Pittsburgh, PA 15213, USA. Electronic address: kransee@upmc.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Evaluating the design and implementation of Kazakhstan's workfare program.", "datePublished": "2023-05-01", "url": "https://questionsmedicales.fr/article/37149977", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.evalprogplan.2023.102301" } }, { "@type": "ScholarlyArticle", "name": "Safer opioid supply: qualitative program evaluation.", "datePublished": "2023-04-20", "url": "https://questionsmedicales.fr/article/37081500", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12954-023-00776-z" } }, { "@type": "ScholarlyArticle", "name": "The directors of resident support program: a program evaluation of a resident well-being and support innovation.", "datePublished": "2024-10-17", "url": "https://questionsmedicales.fr/article/39420361", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12909-024-06176-6" } }, { "@type": "ScholarlyArticle", "name": "Impact of a short-term pharmacy study abroad Program: student outcomes and program evaluation.", "datePublished": "2024-10-02", "url": "https://questionsmedicales.fr/article/39358753", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13104-024-06919-0" } }, { "@type": "ScholarlyArticle", "name": "A mixed-methods program evaluation of the Alda Healthcare Experience- a program to improve healthcare team communication.", "datePublished": "2022-12-28", "url": "https://questionsmedicales.fr/article/36578023", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12909-022-03972-w" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Troubles mentaux", "item": "https://questionsmedicales.fr/mesh/D001523" }, { "@type": "ListItem", "position": 3, "name": "Troubles liés à une substance", "item": "https://questionsmedicales.fr/mesh/D019966" }, { "@type": "ListItem", "position": 4, "name": "Troubles liés à l'usage de substances psychotropes", "item": "https://questionsmedicales.fr/mesh/D000079524" }, { "@type": "ListItem", "position": 5, "name": "Troubles liés aux opiacés", "item": "https://questionsmedicales.fr/mesh/D009293" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Troubles liés aux opiacés - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Troubles liés aux opiacés", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Troubles liés aux opiacés", "description": "Comment diagnostiquer un trouble lié aux opiacés ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels critères DSM sont utilisés pour le diagnostic ?\nQui peut poser le diagnostic ?\nLe diagnostic peut-il être fait à distance ?", "url": "https://questionsmedicales.fr/mesh/D009293?mesh_terms=Program+Evaluation&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Troubles liés aux opiacés", "description": "Quels sont les symptômes courants des troubles liés aux opiacés ?\nComment se manifeste le sevrage des opiacés ?\nLes troubles cognitifs sont-ils fréquents ?\nY a-t-il des symptômes physiques associés ?\nLes symptômes varient-ils selon les individus ?", "url": "https://questionsmedicales.fr/mesh/D009293?mesh_terms=Program+Evaluation&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Troubles liés aux opiacés", "description": "Comment prévenir les troubles liés aux opiacés ?\nLes programmes scolaires aident-ils à la prévention ?\nQuel rôle jouent les médecins dans la prévention ?\nLes campagnes de sensibilisation sont-elles efficaces ?\nComment les familles peuvent-elles aider à prévenir ?", "url": "https://questionsmedicales.fr/mesh/D009293?mesh_terms=Program+Evaluation&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Troubles liés aux opiacés", "description": "Quels traitements sont disponibles pour les troubles liés aux opiacés ?\nQu'est-ce que la méthadone ?\nComment fonctionne la buprénorphine ?\nLa thérapie de groupe est-elle efficace ?\nQuels sont les effets des traitements médicamenteux ?", "url": "https://questionsmedicales.fr/mesh/D009293?mesh_terms=Program+Evaluation&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Troubles liés aux opiacés", "description": "Quelles sont les complications des troubles liés aux opiacés ?\nComment les overdoses se produisent-elles ?\nLes troubles cardiaques sont-ils une complication ?\nLes infections sont-elles un risque ?\nLes troubles respiratoires peuvent-ils survenir ?", "url": "https://questionsmedicales.fr/mesh/D009293?mesh_terms=Program+Evaluation&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Troubles liés aux opiacés", "description": "Quels sont les facteurs de risque des troubles liés aux opiacés ?\nL'âge influence-t-il le risque ?\nLes antécédents de traumatismes augmentent-ils le risque ?\nLe stress est-il un facteur de risque ?\nLes prescriptions médicales abusives sont-elles un risque ?", "url": "https://questionsmedicales.fr/mesh/D009293?mesh_terms=Program+Evaluation&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un trouble lié aux opiacés ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des critères cliniques, l'historique d'usage et des évaluations psychologiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de dépistage de drogues et des évaluations psychologiques sont couramment utilisés." } }, { "@type": "Question", "name": "Quels critères DSM sont utilisés pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Le DSM-5 utilise des critères spécifiques comme la tolérance et le sevrage pour le diagnostic." } }, { "@type": "Question", "name": "Qui peut poser le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un professionnel de santé qualifié, comme un médecin ou un psychologue, peut poser le diagnostic." } }, { "@type": "Question", "name": "Le diagnostic peut-il être fait à distance ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des consultations à distance peuvent aider à évaluer les symptômes et poser un diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des troubles liés aux opiacés ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent l'anxiété, la dépression, des troubles de l'humeur et des problèmes physiques." } }, { "@type": "Question", "name": "Comment se manifeste le sevrage des opiacés ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Le sevrage peut provoquer des douleurs, des nausées, des tremblements et des troubles du sommeil." } }, { "@type": "Question", "name": "Les troubles cognitifs sont-ils fréquents ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de la mémoire et de la concentration sont souvent observés chez les utilisateurs." } }, { "@type": "Question", "name": "Y a-t-il des symptômes physiques associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la constipation, la fatigue et des douleurs corporelles peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les individus ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de la durée et de la quantité d'usage d'opiacés." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés aux opiacés ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par l'éducation, la sensibilisation et l'accès à des soins de santé appropriés." } }, { "@type": "Question", "name": "Les programmes scolaires aident-ils à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les programmes éducatifs en milieu scolaire peuvent réduire l'usage d'opiacés chez les jeunes." } }, { "@type": "Question", "name": "Quel rôle jouent les médecins dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les médecins peuvent sensibiliser les patients aux risques liés à l'usage d'opiacés et prescrire judicieusement." } }, { "@type": "Question", "name": "Les campagnes de sensibilisation sont-elles efficaces ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles augmentent la conscience des dangers des opiacés et encouragent des comportements sains." } }, { "@type": "Question", "name": "Comment les familles peuvent-elles aider à prévenir ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les familles peuvent soutenir la communication ouverte et surveiller les comportements à risque." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles liés aux opiacés ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie comportementale, la médication et le soutien psychosocial." } }, { "@type": "Question", "name": "Qu'est-ce que la méthadone ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La méthadone est un agoniste opioïde utilisé pour traiter la dépendance aux opiacés." } }, { "@type": "Question", "name": "Comment fonctionne la buprénorphine ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La buprénorphine est un agoniste partiel qui aide à réduire les symptômes de sevrage." } }, { "@type": "Question", "name": "La thérapie de groupe est-elle efficace ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie de groupe offre un soutien et des stratégies de coping aux personnes dépendantes." } }, { "@type": "Question", "name": "Quels sont les effets des traitements médicamenteux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements médicamenteux peuvent réduire les cravings et les symptômes de sevrage." } }, { "@type": "Question", "name": "Quelles sont les complications des troubles liés aux opiacés ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des problèmes de santé mentale, des maladies infectieuses et des overdoses." } }, { "@type": "Question", "name": "Comment les overdoses se produisent-elles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les overdoses surviennent souvent par une consommation excessive ou une combinaison avec d'autres substances." } }, { "@type": "Question", "name": "Les troubles cardiaques sont-ils une complication ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'usage d'opiacés peut entraîner des problèmes cardiaques et des troubles circulatoires." } }, { "@type": "Question", "name": "Les infections sont-elles un risque ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les utilisateurs d'opiacés injectables sont à risque accru d'infections comme l'hépatite." } }, { "@type": "Question", "name": "Les troubles respiratoires peuvent-ils survenir ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les opiacés peuvent provoquer des dépressions respiratoires, mettant la vie en danger." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque des troubles liés aux opiacés ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des troubles mentaux et l'accès facile aux opiacés." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes adultes et les adolescents sont particulièrement vulnérables aux troubles liés aux opiacés." } }, { "@type": "Question", "name": "Les antécédents de traumatismes augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant subi des traumatismes sont plus susceptibles de développer des troubles liés aux opiacés." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut augmenter la probabilité de développer une dépendance aux opiacés." } }, { "@type": "Question", "name": "Les prescriptions médicales abusives sont-elles un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des prescriptions inappropriées ou excessives d'opiacés augmentent le risque de dépendance." } } ] } ] }

Sources (10000 au total)

Safer opioid supply: qualitative program evaluation.

As the overdose crisis in Canada continues to escalate in severity, novel interventions and programs are required. Safer Supply programs offer pharmaceutical-grade medication to people who use drugs t... We completed semi-structured interviews and surveys with Safer Supply participants in Ottawa, Canada. Interviews were audio-recorded, transcribed, and analyzed thematically. Descriptive statistics wer... Participants most commonly discussed Safer Supply benefits. This included programs offering a sense of community, connection, hope for the future, and increased autonomy. Participants also described p... Our research demonstrated that participants found Safer Supply to be effective and impactful for their substance use goals. While participants did discuss concerns about the program, overall, we found...

The directors of resident support program: a program evaluation of a resident well-being and support innovation.

Medical training can be a challenging time for residents both professionally and personally. Resident support programs must be able to address a range of potential experiences, be accessible and easy ... The Directors of Resident Support (DRS) program, launched in January 2021 at the Cumming School of Medicine at the University of Calgary, is a near-peer support model consisting of three faculty physi... There were 62 total contacts in the 2-year evaluation period which required a median 2 h to address (range 5 min to more than 40 h). The most common topic for contact was to discuss feedback or evalua... The DRS program has been well-utilized by residents for a variety of issues. Postgraduate Medical Education offices seeking to create resident support programs may anticipate that about 3% of resident...

Impact of a short-term pharmacy study abroad Program: student outcomes and program evaluation.

This study examined the impact of a short-term study abroad program, focusing on program evaluation, attendee satisfaction, and acquired knowledge and skills. A questionnaire survey was conducted cove... Results indicated higher female participation due to gender imbalances in pharmacy students in Egypt, with senior students recognizing the value of international experience. Attendee satisfaction was ...

A mixed-methods program evaluation of the Alda Healthcare Experience- a program to improve healthcare team communication.

Communication among interprofessional healthcare worker teams is critical to ensure a thriving and resilient workforce. We will evaluate the implementation and effectiveness of the Alda Healthcare Exp... Our outcome evaluation will assess the impact of the AHE workshop on short- and long-term improvement in interprofessional communication, stress, and professional fulfillment. The process evaluation c... Effective and efficient communication within healthcare teams is fundamental to building team cohesion that, in turn, supports individual resilience and builds positive organizational culture. The AHE... N/A....

Facilitators and barriers to monitoring and evaluation at syringe service programs.

Syringe services programs (SSPs) provide harm reduction supplies and services to people who use drugs and are often required by funders or partners to collect data from program participants. SSPs can ... Using the Consolidated Framework for Implementation Research (CFIR), we conducted 12 key informant interviews with SSP staff to describe the overall landscape of data systems at SSPs, understand facil... Four main themes emerged from our analysis: SSP M&E systems are primarily designed to be responsive to perceived SSP client needs and preferences; SSP staffing capacity influences the likelihood of mo... Our findings highlight that SSPs are not resistant to data collection and M&E, but face substantial barriers to implementation, including lack of funding and disjointed data reporting requirements. Th...